Amprenavir, new protease inhibitor, approved.
James
J S
JS
D000293:Adolescent; D000328:Adult; D002219:Carbamates; D002648:Child; D002675:Child, Preschool; D017277:Drug Approval; D005663:Furans; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D013449:Sulfonamides / Q000627:therapeutic use*; D014486:United States Food and Drug Administration
D002219:Carbamates; D005663:Furans; D017320:HIV Protease Inhibitors; D013449:Sulfonamides; C095108:amprenavir